Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organigram Global Inc. (OGI : NSDQ)

• Company Description    Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO. Number of Employees: 1,139

• Price / Volume Information    Yesterday's Closing Price: $1.15 Daily Weekly Monthly 20 Day Moving Average: 1,852,407 shares Shares Outstanding: 141.01 (millions) Market Capitalization: $162.86 (millions) Beta: 1.49 52 Week High: $2.24 52 Week Low: $0.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.67% 17.26% 12 Week 8.96% 4.91% Year To Date -31.25% -39.03%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1400-145 King Street West - Toronto,A6 M5H 1J8 CAN ph: 1-844-644-4726 fax: - None http://www.organigram.ca

• General Corporate Information    Officers Beena Goldenberg - Chief Executive Officer Peter Amirault - Chairman Greg Guyatt - Chief Financial Officer Nathalie Batten Kubrick - Senior Vice President of Operations Max Schwartz - Director Peer Information Organigram Global Inc. (BJCT) Organigram Global Inc. (CADMQ) Organigram Global Inc. (APNO) Organigram Global Inc. (UPDC) Organigram Global Inc. (IMTIQ) Organigram Global Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 68617J100 SIC: 2834 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/26 Next Expected EPS Date: 12/15/26 Share - Related Items Shares Outstanding: 141.01 Most Recent Split Date: 7.00 (0.25:1) Beta: 1.49 Market Capitalization: $162.86 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.11 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 12/15/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.46 Price/Cash Flow: - Price / Sales: 0.73 EPS Growth vs. Year Ago Period: -66.67% vs. Previous Quarter: -400.00% Sales Growth vs. Year Ago Period: 49.35% vs. Previous Quarter: 75.30% ROE 06/30/26 - -13.39 03/31/26 - -13.41 12/31/25 - -15.41 ROA 06/30/26 - -8.67 03/31/26 - -9.09 12/31/25 - -10.49 Current Ratio 06/30/26 - 2.61 03/31/26 - 2.82 12/31/25 - 2.73 Quick Ratio 06/30/26 - 1.07 03/31/26 - 1.30 12/31/25 - 1.32 Operating Margin 06/30/26 - -17.09 03/31/26 - -18.09 12/31/25 - -20.59 Net Margin 06/30/26 - 28.14 03/31/26 - -9.22 12/31/25 - 6.03 Pre-Tax Margin 06/30/26 - 26.88 03/31/26 - -13.68 12/31/25 - 1.59 Book Value 06/30/26 - 2.49 03/31/26 - 1.93 12/31/25 - 1.96 Inventory Turnover 06/30/26 - 1.41 03/31/26 - 1.37 12/31/25 - 1.46 Debt-to-Equity 06/30/26 - 0.04 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 15.44 03/31/26 - 12.58 12/31/25 - 12.96

Powered by Zacks Investment Research ©